D. Stainsby

2.1k total citations
23 papers, 1.4k citations indexed

About

D. Stainsby is a scholar working on Biochemistry, Management of Technology and Innovation and Critical Care and Intensive Care Medicine. According to data from OpenAlex, D. Stainsby has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biochemistry, 14 papers in Management of Technology and Innovation and 9 papers in Critical Care and Intensive Care Medicine. Recurrent topics in D. Stainsby's work include Blood transfusion and management (16 papers), Blood donation and transfusion practices (14 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (9 papers). D. Stainsby is often cited by papers focused on Blood transfusion and management (16 papers), Blood donation and transfusion practices (14 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (9 papers). D. Stainsby collaborates with scholars based in United Kingdom and Nigeria. D. Stainsby's co-authors include Sheila MacLennan, Hannah Cohen, Dafydd G. Thomas, P. J. Hamilton, Hilary Jones, Patrick Hamilton, Lorna M. Williamson, C. Chapman, Elizabeth M. Love and Geoff Lucas and has published in prestigious journals such as British Journal of Haematology, British Journal of Anaesthesia and Transfusion.

In The Last Decade

D. Stainsby

23 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D. Stainsby 890 648 413 397 242 23 1.4k
James R. Stubbs 741 0.8× 810 1.3× 445 1.1× 384 1.0× 530 2.2× 93 1.8k
Shannon L. Farmer 1.2k 1.4× 633 1.0× 440 1.1× 515 1.3× 144 0.6× 44 1.6k
Claire Atterbury 563 0.6× 416 0.6× 279 0.7× 301 0.8× 118 0.5× 10 947
Laura Green 464 0.5× 900 1.4× 346 0.8× 196 0.5× 606 2.5× 90 2.1k
Arthur Bracey 470 0.5× 436 0.7× 428 1.0× 130 0.3× 300 1.2× 66 1.8k
S. Allard 456 0.5× 739 1.1× 383 0.9× 86 0.2× 542 2.2× 25 1.4k
Kevin M. Trentino 730 0.8× 359 0.6× 247 0.6× 301 0.8× 119 0.5× 42 1.0k
Gregory J. Pomper 443 0.5× 772 1.2× 262 0.6× 139 0.4× 638 2.6× 21 1.2k
S. Knowles 377 0.4× 185 0.3× 376 0.9× 137 0.3× 83 0.3× 18 847
Louise Choo 381 0.4× 164 0.3× 415 1.0× 126 0.3× 46 0.2× 21 920

Countries citing papers authored by D. Stainsby

Since Specialization
Citations

This map shows the geographic impact of D. Stainsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Stainsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Stainsby more than expected).

Fields of papers citing papers by D. Stainsby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Stainsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Stainsby. The network helps show where D. Stainsby may publish in the future.

Co-authorship network of co-authors of D. Stainsby

This figure shows the co-authorship network connecting the top 25 collaborators of D. Stainsby. A scholar is included among the top collaborators of D. Stainsby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Stainsby. D. Stainsby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stainsby, D., Susan J Brunskill, C. Chapman, Carolyn Dorée, & Simon Stanworth. (2009). Safety of blood donation from individuals with treated hypertension or non‐insulin dependent type 2 diabetes – a systematic review. Vox Sanguinis. 98(3p2). 431–440. 15 indexed citations
2.
Chapman, C., D. Stainsby, Hilary Jones, et al.. (2009). Ten years of hemovigilance reports of transfusion‐related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 49(3). 440–452. 268 indexed citations
3.
Stainsby, D., et al.. (2008). Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996–2005. British Journal of Haematology. 141(1). 73–79. 125 indexed citations
4.
Stainsby, D., et al.. (2007). Reports to the serious hazards of transfusion (SHOT) scheme of post-transfusion purpura (PTP) and transfusion-associated graft-versus-host disease (TA-GvHD) before and after implementation of universal leucodepletion in the UK.. 31–3. 1 indexed citations
5.
6.
Williamson, Lorna M., D. Stainsby, Hilary Jones, et al.. (2007). The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host disease. Transfusion. 47(8). 1455–1467. 71 indexed citations
7.
Cohen, H, et al.. (2006). The impact of using male donor plasma on haemovigilance reports of transfusion related acute lung injury (TRALI) in the UK. UCL Discovery (University College London). 16 indexed citations
8.
Stainsby, D., Hilary Jones, Deborah Asher, et al.. (2006). Serious Hazards of Transfusion: A Decade of Hemovigilance in the UK. Transfusion Medicine Reviews. 20(4). 273–282. 265 indexed citations
9.
Stainsby, D., et al.. (2006). Guidelines on the management of massive blood loss. British Journal of Haematology. 135(5). 634–641. 276 indexed citations
10.
Stainsby, D.. (2005). Errors in Transfusion Medicine. Anesthesiology Clinics of North America. 23(2). 253–261. 13 indexed citations
11.
Stainsby, D.. (2005). ABO incompatible transfusions—experience from the UK Serious Hazards of Transfusion (SHOT) scheme. Transfusion Clinique et Biologique. 12(5). 385–388. 40 indexed citations
12.
Stainsby, D., et al.. (2005). Reducing adverse events in blood transfusion. British Journal of Haematology. 131(1). 8–12. 78 indexed citations
13.
Stainsby, D.. (2004). Haemovigilance in the United Kingdom and Europe. The Hematology Journal. 5. S175–S178. 6 indexed citations
14.
Stainsby, D., Lorna M. Williamson, Hilary Jones, & Hannah Cohen. (2004). 6 Years of shot reporting—its influence on UK blood safety. Transfusion and Apheresis Science. 31(2). 123–131. 37 indexed citations
15.
Stainsby, D., Hilary Jones, D. Stainsby, et al.. (2004). by The Serious Hazards of Transfusion Steering Group. 27 indexed citations
16.
Wallis, J. P., D. Stainsby, & D. B. L. McClelland. (2002). Audit of red cell transfusion. Transfusion Medicine. 12(1). 1–9. 14 indexed citations
17.
Stainsby, D., Sheila MacLennan, & Patrick Hamilton. (2000). Management of massive blood loss: a template guideline. British Journal of Anaesthesia. 85(3). 487–491. 147 indexed citations
18.
Melzer, Mark, et al.. (1998). Cryptococcosis: An unusual opportunistic infection complicating B cell lymphoproliferative disorders. Journal of Infection. 36(2). 220–222. 10 indexed citations
19.
Simpson, F G, et al.. (1993). RED CELL MACROCYTOSIS AND CHRONIC OBSTRUCTIVE AIRWAYS DISEASE. British Journal of Haematology. 83(1). 174–176. 5 indexed citations
20.
Stainsby, D., et al.. (1983). Papilloedema in chronic granulocytic leukaemia. British Journal of Haematology. 55(2). 243–249. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026